摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 935248-40-1

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
935248-40-1
化学式
C21H19ClN2O3
mdl
——
分子量
382.846
InChiKey
BSHZPKVDSOHJPU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.98
  • 重原子数:
    27.0
  • 可旋转键数:
    7.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    65.22
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    环戊基甲醇三乙酰氧基硼氢化钠 作用下, 生成 (1-(3-(6-((5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl)methoxy)-2,3-dihydro-1H-inden-1-yl)propylamino)cyclopentyl)methanol
    参考文献:
    名称:
    A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening
    摘要:
    The synthesis and structure-activity relationships (SAR) of a series of indane and tetralin inhibitors of the type 1 glycine transporter, derived from a high-throughput screening (HTS) hit, are described. Key modifications that reduced the 5HT1B receptor affinity of the HTS hit and the P450 2D6 inhibition of subsequent analogues are delineated. While these modifications led to potent and selective GlyT1 inhibitors, HERG affinity and human microsomal clearance remain an issue for this series of compounds. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.12.109
  • 作为产物:
    描述:
    四丁基碘化铵 氯化亚砜 、 dimethyl sulfide borane 、 二异丁基氢化铝 作用下, 以 四氢呋喃正庚烷1,2-二氯乙烷甲苯乙腈 为溶剂, 反应 103.0h, 生成
    参考文献:
    名称:
    A novel, non-substrate-based series of glycine type 1 transporter inhibitors derived from high-throughput screening
    摘要:
    The synthesis and structure-activity relationships (SAR) of a series of indane and tetralin inhibitors of the type 1 glycine transporter, derived from a high-throughput screening (HTS) hit, are described. Key modifications that reduced the 5HT1B receptor affinity of the HTS hit and the P450 2D6 inhibition of subsequent analogues are delineated. While these modifications led to potent and selective GlyT1 inhibitors, HERG affinity and human microsomal clearance remain an issue for this series of compounds. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.12.109
点击查看最新优质反应信息